SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on August 26, 2020, covering the event date of August 25, 2020. The registrant is a Delaware corporation with principal executive offices in Westport, Connecticut, and its common stock trades on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material changes to financial position or operations are reported in this document. The filing serves solely to disclose a scheduled corporate presentation.
Guidance, Outlook, and Management Commentary
Management announced via press release (Exhibit 99.1) that the Company will present at the 12th Annual LD 500 Conference on Wednesday, September 2, 2020, at 11:40 AM ET. The Company explicitly stated it undertakes no obligation to update, supplement, or amend the materials attached to this filing. No specific financial guidance or risk factors were detailed in the text of this 8-K.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details regarding the September 2, 2020 conference presentation.
- Confirm the Company's current financial status by reviewing the most recent 10-Q or 10-K filings, as this 8-K contains no financial data.
- Note that the information in Item 7.01 is not deemed "filed" for purposes of Section 18 of the Exchange Act and is not incorporated by reference unless expressly stated.